Journal issues > Issue 8, December 2023 > New haematology reimbursements in Belgium: NPLATE® (ROMIPLOSTIM), BEKEMV® (ECULIZUMAB), YESCARTA® (AXICABTAGENE CILOLEUCEL, AXI-CEL)

New haematology reimbursements in Belgium: NPLATE® (ROMIPLOSTIM), BEKEMV® (ECULIZUMAB), YESCARTA® (AXICABTAGENE CILOLEUCEL, AXI-CEL)

By: T. Feys MBA, MSc

OVERVIEW OF BELGIAN REIMBURSEMENT NEWS

(BELG J HEMATOL 2023;14(8):355)

To read the full artice you have the following options:

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €3.03

** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top